Welcoming David Benrimoh to the Douglas Research Centre

September 5, 2023

We are pleased to welcome Dr. David Benrimoh, who joined the Douglas Research Centre in July 2023. Dr. Benrimoh joins us as a clinical researcher, holding an appointment as an Assistant Professor in the Department of Psychiatry at McGill University, as well as being a neuropsychiatrist here at the Douglas Mental Health University Institute.

Dr. Benrimoh completed his psychiatry residency at McGill before pursuing an MSc. in Neuroscience from University College London, working with Karl Friston on computational models of auditory hallucinations. He obtained a second MSc. in Psychiatry from McGill, working with Dr. Simon Ducharme and Bratislav Misic on transdiagnostic imaging in psychosis. More recently, he completed his fellowship in Neuropsychiatry at Stanford University, where he conducted research on the mechanistic underpinnings of rapid acting rTMS. He is the author of over 40 peer-reviewed publications, and has already received several prizes and distinctions.

Here at the Douglas, Dr. Benrimoh’s research will focus on computational psychiatry approaches to understanding and predicting psychosis onset and using this knowledge to develop novel treatment paradigms, while his clinical work will be focused in psychotic disorders, with a focus on early psychosis. He also hopes to set up a neuropsychiatric consultation clinic for functional neurological disorder and other neuropsychiatric conditions. 

In addition to his clincial and academic endeavours, Dr. Benrimoh is the founder and chief science officer at Aifred Health, a digital mental health company using artificial intelligence to create decision support tools for mental health clinicians; Aifred won the $1M USD second place prize in the global IBM-sponsored AI XPRIZE.

Welcome, Dr. Benrimoh!